These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36407489)

  • 1. The role of image-guided radiotherapy in prostate cancer: A systematic review and meta-analysis.
    Wang S; Tang W; Luo H; Jin F; Wang Y
    Clin Transl Radiat Oncol; 2023 Jan; 38():81-89. PubMed ID: 36407489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial.
    de Crevoisier R; Bayar MA; Pommier P; Muracciole X; Pêne F; Dudouet P; Latorzeff I; Beckendorf V; Bachaud JM; Laplanche A; Supiot S; Chauvet B; Nguyen TD; Bossi A; Créhange G; Lagrange JL
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1420-1429. PubMed ID: 30071296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of treatment outcome between fiducial-based and bone-based image guided radiotherapy in prostate cancer patients.
    Napieralska A; Majewski W; Kulik R; Głowacki G; Miszczyk L
    Radiat Oncol; 2018 Nov; 13(1):235. PubMed ID: 30482212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.
    Zelefsky MJ; Kollmeier M; Cox B; Fidaleo A; Sperling D; Pei X; Carver B; Coleman J; Lovelock M; Hunt M
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):125-9. PubMed ID: 22330997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image-guided radiation therapy produces lower acute and chronic gastrointestinal and genitourinary toxicity in prostate cancer patients.
    Stuk J; Vanasek J; Odrazka K; Dolezel M; Kolarova I; Hlavka A; Vitkova M; Sinkorova Z
    J BUON; 2021; 26(3):940-948. PubMed ID: 34268957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Toxicity of Whole Pelvic Radiotherapy Versus Prostate-Only Radiotherapy in Localized Prostate Cancer: A Systematic Review and Meta-Analysis.
    Wang S; Tang W; Luo H; Jin F; Wang Y
    Front Oncol; 2021; 11():796907. PubMed ID: 35155197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive image-guided radiotherapy (IGRT) eliminates the risk of biochemical failure caused by the bias of rectal distension in prostate cancer treatment planning: clinical evidence.
    Park SS; Yan D; McGrath S; Dilworth JT; Liang J; Ye H; Krauss DJ; Martinez AA; Kestin LL
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):947-52. PubMed ID: 22208964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing radiation-associated toxicity using online image guidance (IGRT) in prostate cancer patients undergoing dose-escalated radiation therapy.
    Becker-Schiebe M; Abaci A; Ahmad T; Hoffmann W
    Rep Pract Oncol Radiother; 2016; 21(3):188-94. PubMed ID: 27601949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse relationship between biochemical outcome and acute toxicity after image-guided radiotherapy for prostate cancer.
    Vesprini D; Catton C; Jacks L; Lockwood G; Rosewall T; Bayley A; Chung P; Gospodarowicz M; Ménard C; Milosevic M; Nichol A; Skala M; Warde P; Bristow RG
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):608-16. PubMed ID: 22099034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionation.
    Jereczek-Fossa BA; Surgo A; Maisonneuve P; Maucieri A; Gerardi MA; Zerini D; Marvaso G; Ciardo D; Volpe S; Rojas DP; Riva G; Alessandro O; Dicuonzo S; Fanetti G; Romanelli P; Starzyńska A; Cattani F; Cambria R; Fodor C; Garibaldi C; Romanò C; De Cobelli O; Orecchia R
    Radiol Med; 2019 Jan; 124(1):65-78. PubMed ID: 30219945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image guided dose escalated prostate radiotherapy: still room to improve.
    Martin JM; Bayley A; Bristow R; Chung P; Gospodarowicz M; Menard C; Milosevic M; Rosewall T; Warde PR; Catton CN
    Radiat Oncol; 2009 Nov; 4():50. PubMed ID: 19887007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy for prostate cancer - Does daily image guidance with tighter margins improve patient reported outcomes compared to weekly orthogonal verified irradiation? Results from a randomized controlled trial.
    Tøndel H; Lund JÅ; Lydersen S; Wanderås AD; Aksnessæther B; Jensen CA; Kaasa S; Solberg A
    Radiother Oncol; 2018 Feb; 126(2):229-235. PubMed ID: 29398152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing radiation dose for postoperative radiotherapy in prostate cancer: Real world data.
    Hervás-Morón A; Domínguez-Rullán J; Santana VD; Valero M; Vallejo C; Sancho S; Fuentes JDG; López-Campos F; Gallego MC
    World J Clin Oncol; 2022 Jul; 13(7):652-662. PubMed ID: 36157159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer.
    Mohammed N; Kestin L; Ghilezan M; Krauss D; Vicini F; Brabbins D; Gustafson G; Ye H; Martinez A
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):204-12. PubMed ID: 21167653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypofractionation for clinically localized prostate cancer.
    Hickey BE; James ML; Daly T; Soh FY; Jeffery M
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011462. PubMed ID: 31476800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer.
    Guckenberger M; Ok S; Polat B; Sweeney RA; Flentje M
    Strahlenther Onkol; 2010 Oct; 186(10):535-43. PubMed ID: 20890743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate hypofractionated radiotherapy vs conventional fractionated radiotherapy in localized prostate cancer: a systemic review and meta-analysis from Phase III randomized trials.
    Yin Z; You J; Wang Y; Zhao J; Jiang S; Zhang X; Wang P; Tao Z; Wang X; Yuan Z
    Onco Targets Ther; 2019; 12():1259-1268. PubMed ID: 30863093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionation.
    Jereczek-Fossa BA; Zerini D; Fodor C; Santoro L; Cambria R; Garibaldi C; Tagaste B; Vavassori A; Cattani F; Alterio D; Gherardi F; Serafini F; Rocco B; Musi G; De Cobelli O; Orecchia R
    Urol Oncol; 2011; 29(5):523-32. PubMed ID: 20005749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.
    Peeters ST; Heemsbergen WD; van Putten WL; Slot A; Tabak H; Mens JW; Lebesque JV; Koper PC
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1019-34. PubMed ID: 15752881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial.
    Ma TM; Lamb JM; Casado M; Wang X; Basehart TV; Yang Y; Low D; Sheng K; Agazaryan N; Nickols NG; Cao M; Steinberg ML; Kishan AU
    BMC Cancer; 2021 May; 21(1):538. PubMed ID: 33975579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.